- A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer. Miller, K.D., Saphner, T.J., Waterhouse, D.M., Chen, T.T., Rush-Taylor, A., Sparano, J.A., Wolff, A.C., Cobleigh, M.A., Galbraith, S., Sledge, G.W. Clin. Cancer Res. (2004)